U.S. flag

An official website of the United States government

NM_006172.4(NPPA):c.190A>C (p.Ser64Arg) AND Atrial fibrillation, familial, 6

Germline classification:
Benign (2 submissions)
Last evaluated:
Jan 18, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000114741.16

Allele description [Variation Report for NM_006172.4(NPPA):c.190A>C (p.Ser64Arg)]

NM_006172.4(NPPA):c.190A>C (p.Ser64Arg)

Genes:
NPPA-AS1:NPPA antisense RNA 1 [Gene - HGNC]
LOC114827827:VISTA enhancer hs2123 [Gene]
NPPA:natriuretic peptide A [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p36.22
Genomic location:
Preferred name:
NM_006172.4(NPPA):c.190A>C (p.Ser64Arg)
HGVS:
  • NC_000001.11:g.11847373T>G
  • NG_012926.1:g.5411A>C
  • NG_065183.1:g.655T>G
  • NM_006172.4:c.190A>CMANE SELECT
  • NP_006163.1:p.Ser64Arg
  • LRG_751t1:c.190A>C
  • LRG_751:g.5411A>C
  • NC_000001.10:g.11907430T>G
  • NM_006172.3:c.190A>C
Protein change:
S64R; SER64ARG
Links:
OMIM: 108780.0002; dbSNP: rs61757261
NCBI 1000 Genomes Browser:
rs61757261
Molecular consequence:
  • NM_006172.4:c.190A>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Atrial fibrillation, familial, 6 (ATFB6)
Identifiers:
MONDO: MONDO:0012816; MedGen: C2677294; OMIM: 612201

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000148624OMIM
no assertion criteria provided
Pathogenic
(Jan 1, 2010)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV000289138Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Benign
(Jan 18, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Augmented potassium current is a shared phenotype for two genetic defects associated with familial atrial fibrillation.

Abraham RL, Yang T, Blair M, Roden DM, Darbar D.

J Mol Cell Cardiol. 2010 Jan;48(1):181-90. doi: 10.1016/j.yjmcc.2009.07.020. Epub 2009 Jul 30.

PubMed [citation]
PMID:
19646991
PMCID:
PMC2813326

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From OMIM, SCV000148624.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In affected members of a Caucasian kindred segregating autosomal dominant early-onset lone atrial fibrillation (ATFB6; 602201), Abraham et al. (2010) identified heterozygosity for a c.190A-C transversion in exon 2 of the NPPA gene, resulting in a ser64-to-arg (S64R) substitution at a conserved residue in the proANP peptide. The missense mutation segregated with disease in the family and was not found in Caucasian, Han Chinese, Asian, or African American population controls. Abraham et al. (2010) noted that ANP levels were not significantly different between family members with AF who were mutations carriers and those who were unaffected and did not carry the mutation. Functional analysis in CHO cells demonstrated that coexpression of mutant NPPA with its ancillary subunit KCNE1 (176261) generated a significantly larger current compared to wildtype, which also activated earlier than wildtype currents. The mutant accelerated both activation and deactivation over all voltages. Pretreatment with anantin, a competitive ANP receptor antagonist, completely eliminated current augmentation and acceleration seen with the mutant, indicating that the effect of the S64R fragment on current is mediated by the endogenous ANP receptor.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000289138.10

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 13, 2024